Ferenc E. Mozes

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Erratum: Noninvasive assessment of liver disease severity in NAFLD and T2D.

Erratum: Noninvasive assessment of liver disease severity in NAFLD and T2D.

Journal: Hepatology (Baltimore, Md.)

Published: July 17, 2026

Slowing Down Water: Enhanced and Cation-responsive MRI Contrast.

Slowing Down Water: Enhanced and Cation-responsive MRI Contrast.

Journal: Angewandte Chemie (International ed. in English)

Published: February 04, 2026

Faster and More Robust CK Reaction Rate Estimation at 3T Using Acquisition-Weighted 31P Cardiac 1D-MRSI With Compartment-Based Reconstruction.

Faster and More Robust CK Reaction Rate Estimation at 3T Using Acquisition-Weighted 31P Cardiac 1D-MRSI With Compartment-Based Reconstruction.

Journal: Magnetic resonance in medicine

Published: February 03, 2026

Changes in hepatic L-carnitine levels in people with metabolic dysfunction-associated steatotic liver disease (MASLD) assessed by magnetic resonance techniques.

Changes in hepatic L-carnitine levels in people with metabolic dysfunction-associated steatotic liver disease (MASLD) assessed by magnetic resonance techniques.

Journal: Scientific reports

Published: December 19, 2025

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Journal: Circulation

Published: December 18, 2025

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.

Journal: Nature medicine

Published: December 11, 2025

Repeatability of Rapid Human Cardiac Phosphorus MRSI (31P-MRSI) Using Concentric Ring Trajectory Readouts at 7 T.

Repeatability of Rapid Human Cardiac Phosphorus MRSI (31P-MRSI) Using Concentric Ring Trajectory Readouts at 7 T.

Journal: Magnetic resonance in medicine

Published: July 04, 2025

Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.

Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.

Journal: MedComm

Published: March 12, 2025

Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD.

Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD.

Journal: JHEP reports : innovation in hepatology

Published: October 25, 2024

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.

Journal: Gut microbes

Published: September 28, 2024

Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial.

Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial.

Journal: Journal of cachexia, sarcopenia and muscle

Published: August 08, 2024

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans.

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans.

Journal: European journal of endocrinology

Published: January 29, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026